Detroit、MIにおける前立腺がんの臨床試験
Detroitとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
被験者募集中健康なボランティア歓迎
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
被験者募集中第3相
- Henry Ford Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
被験者募集中第2相
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
被験者募集中第3相
- Henry Ford Hospital ( Site 0015), Detroit
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
被験者募集中第1/2相
- Research Site, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
被験者募集中第1相
- Barbara Ann Karmanos Cancer Institute, Detroit
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
被験者募集中第3相
- Karmanos Cancer Institute, Detroit
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
被験者募集中第3相
- Henry Ford Hospital ( Site 0035), Detroit
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
被験者募集中
- Wayne State University, Detroit
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
被験者募集中第3相
- Henry Ford Hospital, Detroit
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
被験者募集中第1/2相
- Karmanos Cancer Institute, Detroit
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
被験者募集中第3相
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
被験者募集中第1相
- Karmanos, Detroit
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
被験者募集中
- Karmanos Cancer Institute, Detroit
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
被験者募集中観察研究
- Karmanos Cancer Institute, Detroit
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1/2相
- Karmanos Cancer Institute, Detroit
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1/2相
- Barbara Ann Karmanos Cancer Institute, Detroit
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
被験者募集中第3相
- Henry Ford Health Saint John Hospital, Detroit
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
被験者募集中
- Henry Ford Health, Detroit
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site 129, Detroit
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
他の都市における前立腺がんの試験
- New York City, NY103件の研究
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN43件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
Detroitにおける他の研究
- 非小細胞肺癌44件の研究
- 乳がん33件の研究
- がん（全種類）29件の研究
- 大腸癌26件の研究
- 卵巣がん26件の研究
- 転移性癌24件の研究
- 子宮内膜がん21件の研究
- 肺がん20件の研究
- 多発性骨髄腫19件の研究
- 胃癌16件の研究
- 頭頸部扁平上皮癌15件の研究
- 急性骨髄性白血病14件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。